Barclays’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.33M | Sell |
|
|||||
|
2025
Q2 | $5.35M | Buy |
|
|||||
|
2025
Q1 | $2.12M | Sell |
|
|||||
|
2024
Q4 | $3.61M | Buy |
|
|||||
|
2024
Q3 | $4.43M | Buy |
|
|||||
|
2024
Q2 | $2M | Sell |
|
|||||
|
2024
Q1 | $2.8M | Sell |
|
|||||
|
2023
Q4 | $5.79M | Buy |
|
|||||
|
2023
Q3 | $3.95M | Sell |
|
|||||
|
2023
Q2 | $5.84M | Buy |
|
|||||
|
2023
Q1 | $3.92M | Sell |
|
|||||
|
2022
Q4 | $5.19M | Sell |
|
|||||
|
2022
Q3 | $4.06M | Buy |
|
|||||
|
2022
Q2 | $2.62M | Sell |
|
|||||
|
2022
Q1 | $7.04M | Buy |
|
|||||
|
2021
Q4 | $5.41M | Buy |
|
|||||
|
2021
Q3 | $2.15M | Buy |
|
|||||
|
2021
Q2 | $730K | Sell |
|
|||||
|
2021
Q1 | $1.14M | Buy |
|
|||||
|
2020
Q4 | $9K | Sell |
|
|||||
|
2020
Q3 | $13K | Buy |
|
|||||
|
2020
Q2 | $0 | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $0 | Sell |
|
|||||
|
2019
Q2 | $10K | Sell |
|
|||||
|
2019
Q1 | $45K | Buy |
|
|||||
|
2018
Q4 | $0 | Sell |
|
|||||
|
2018
Q3 | $3K | Sell |
|
|||||
|
2018
Q2 | $89K | Buy |
|
|||||
|
2018
Q1 | $97K | Buy |
|
|||||
|
2017
Q4 | $59K | Buy |
|
|||||
|
2017
Q3 | $13K | Buy |
|
|||||
|
2017
Q2 | $2K | Sell |
|
|||||
|
2017
Q1 | $68K | Buy |
|
|||||
|
2016
Q4 | $32K | Buy |
|
|||||
|
2016
Q3 | $33K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $99K | Sell |
|
|||||
|
2015
Q4 | $3.03M | Buy |
|
|||||
|
2015
Q3 | $279K | Buy |
|
|||||
|
2015
Q2 | $124K | Buy |
|
|||||
|
2015
Q1 | $75K | Sell |
|
|||||
|
2014
Q4 | $783K | Sell |
|
|||||
|
2014
Q3 | $642K | Buy |
|
|||||
|
2014
Q2 | $769K | Sell |
|
|||||
|
2014
Q1 | $1.12M | Sell |
|
|||||
|
2013
Q4 | $3.17M | Buy |
|
|||||
|
2013
Q3 | $2.45M | Buy |
|
|||||
|
2013
Q2 | $184K | Buy |
|